Review of chemotherapy-associated paronychia

Int J Dermatol. 2022 Apr;61(4):410-415. doi: 10.1111/ijd.15740. Epub 2021 Jul 9.

Abstract

Chemotherapy-associated paronychia (CAP) is an inflammation of the nail folds in response to various chemotherapeutic medications. Altered proliferation of keratinocytes or nail matrix stem cells is thought to be a major causative factor. Prophylactic tetracyclines, topical povidone-iodine, and general irritation avoidance measures are among some of the recommended interventions for CAP. Appropriate recognition and treatment of CAP are important for prevention of chemotherapy dose reduction or medication discontinuation.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Chronic Disease
  • Humans
  • Nails
  • Paronychia* / drug therapy
  • Paronychia* / therapy
  • Tetracyclines

Substances

  • Anti-Bacterial Agents
  • Tetracyclines